Novozymes A/S (CPH:NSIS.B)
436.60
-14.00 (-3.11%)
Sep 4, 2026, 4:59 PM CET
Novozymes Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Novozymes stock has a consensus rating of "Buy" and an average price target of kr 491.93. The average 1-year stock price forecast is 12.67% higher than the current stock price, while the lowest is kr 414.00 (-5.18%) and the highest is kr 540.00 (+23.68%).
Price Target: kr 491.93 (+12.67%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Novozymes stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 11 | 11 | 10 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 2 | 2 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 16 | 15 |
Financial Forecast
Revenue This Year
4.48B
from 4.16B
Increased by 7.66%
Revenue Next Year
4.80B
from 4.48B
Increased by 7.17%
EPS This Year
2.16
from 1.99
Increased by 8.39%
EPS Next Year
2.39
from 2.16
Increased by 10.59%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.